# Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion

> **NCT05787678** · — · UNKNOWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 30 (estimated)

## Conditions studied

- Asthma; Eosinophilic

## Interventions

- **BIOLOGICAL:** Dupilumab

## Key facts

- **NCT ID:** NCT05787678
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787678, "Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05787678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*